Peer Group

Configuration
Company Price d* Change d* Volume, Avg. k, d* Market Cap. d* Revenue Profit Net Earnings Free Cash Flow Dividend Yield P/E EPS Gross Margin % Net Margin % ROE % ROA % Quick Ratio % Shares Outstanding d*
Drug Manufacturers—General Average - - - - - - 81,033.08 7,198.83 999.92 4,608.30 -206.50 0.28 22.2529 0.80 59.4775 12.0680 1.33 4.77 101.0370 - -
Maximum - - - - - - 244,635.00 13,765.00 2,179.00 18,021.00 1,154.00 0.89 46.2856 2.71 76.7200 22.0300 2.70 15.33 350.2200 - -
Minimum - - - - - - 0.00 944.00 19.00 0.00 -2,626.00 0.00 0.8741 0.06 6.4100 1.2400 0.00 0.97 0.0000 - -
AbbVie Inc. ABBV 192.94 -0.51 -0.26% 2,474 vs. 5,220 340,797.00 12,310.00 1,369.00 3,847.00 -2,384.00 0.7700 58.3938 0.87 66.84 11.12 17.10 0.92 72.29 1,766.00
Gilead Sciences, Inc. GILD 83.89 0.84 1.01% 9,192 vs. 6,997 104,442.00 6,686.00 -4,170.00 2,114.00 10,656.00 -3.3400 -5.4485 1.09 76.79 -62.37 -23.78 -7.41 82.43 1,244.00
Bristol-Myers Squibb Company BMY 49.74 0.25 0.51% 5,492 vs. 14,238 100,842.00 11,865.00 -11,911.00 2,550.00 15,640.00 -5.8900 -2.2500 1.13 75.29 -100.39 -72.23 -12.03 91.90 2,027.00
Pfizer Inc. PFE 29.75 -0.08 -0.27% 22,124 vs. 31,706 168,584.00 14,879.00 3,115.00 387.00 121,318.00 0.5500 12.5852 1.51 70.56 20.94 3.38 1.41 56.59 5,666.00
Amgen Inc. AMGN 332.92 0.12 0.04% 1,299 vs. 2,067 178,887.00 7,396.00 -113.00 459.00 -27,870.00 -0.2100 -335.6404 0.80 56.73 -1.53 -2.25 -0.12 83.62 537.00
Eli Lilly and Company LLY 904.97 -1.21 -0.13% 1,435 vs. 3,199 860,107.00 8,768.00 2,242.00 179.00 12,553.00 2.4900 76.3636 0.17 82.50 25.58 17.51 3.51 67.75 950.00
Merck & Co., Inc. MRK 118.64 0.35 0.30% 9,605 vs. 9,844 300,729.00 15,809.00 4,762.00 2,229.00 56,697.00 1.8800 17.4190 0.59 75.11 30.12 11.80 4.50 72.84 2,534.00
Johnson & Johnson JNJ 166.15 -0.92 -0.55% 3,381 vs. 6,838 399,962.00 21,382.00 3,255.00 2,850.00 153,378.00 1.3500 29.1832 0.76 68.78 15.22 4.65 1.89 84.48 2,407.00
*d means the data is delayed 15 minutes at minimum.
More Due Diligence
Compare Fundamentals
Leverage our visualization and data tables to compare over 25 years of financial data for AAPL and its peers.
Watchlist
Keep an eye one one or all of the stocks by building a new watchlist.
Intrinsic Values
Utilize our versatile Gordan Growth Model for JNJ and its peers to uncover potential buy and sell opportunities.